Foley & Lardner LLP represented Riverwood Capital on the deal while Cooley advised Sanabil. O’Melveny advised Alation. Riverwood Capital, a technology-focused growth equity fund, acted as an...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
You must be a Standard 1 Year member to access this content.
Cooley advised Welsbach Technology Metals Acquisition Corp. on the deal. Welsbach Technology Metals Acquisition Corp., a publicly traded special purpose acquisition company, announced its definitive merger agreement...
You must be a Standard 1 Year member to access this content.
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Cooley advised LEVVELS on the deal. LEVVELS announced the introduction of MOMENTICA, a flagship platform for fan-artist engagement built on sustainable blockchain technology. LEVVELS is a joint...
You must be a Standard 1 Year member to access this content.
Koley and Jessen advised Traive, while Veirano Advogados and Cooley advised BASF VC on the deal. Traive closed its Pre-Series B investment round of US$10 million led...
You must be a Standard 1 Year member to access this content.
Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
You must be a Standard 1 Year member to access this content.
Cooley advised Glasswing Ventures on the deal. Glasswing Ventures, an early-stage venture capital firm, announced its oversubscribed $158 million Fund II. Founded in 2016 and headquartered in...
You must be a Standard 1 Year member to access this content.
Cooley advised Razor’s Edge on the deal. Razor’s Edge, a top national security-focused technology investor, announced its oversubscribed $340 million third investment fund. Significantly exceeding Razor’s Edge’s...
You must be a Standard 1 Year member to access this content.
Cooley advised Lerer Hippeau on the deal. Lerer Hippeau, an early-stage venture capital firm, announced the formation of two new funds – LH Seed VIII and LH...
You must be a Standard 1 Year member to access this content.
Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
You must be a Standard 1 Year member to access this content.
Jones Day advised Pigment on the deal. Viguié Schmidt & Associés and Cooley advised Meritech Capital and IVP. Pigment, a French startup developing a business planning...
You must be a Standard 1 Year member to access this content.
